Full text
Earnings transcript
Read the complete earnings call transcript.
IOSP
Innospec Inc.
$73.79
0.19
(0.26%)
| Exchange: | NASDAQ |
| Market Cap: | 1.828B |
| Shares Outstanding: | 29.028M |
About The Company
| Sector: | Basic Materials | |||||
| Industry: | Chemicals – Specialty | |||||
| CEO: | Patrick S. Williams | |||||
| Full Time Employees: | 2450 | |||||
| Address: |
| |||||
| Website: | https://innospec.com |
Innospec Inc. develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company’s Fuel Specialties segment offers a range of specialty chemical products that are used as additives in various fuels. This segment’s products are used in the operation of automotive, marine, and aviation engines; power station generators; and heating oil. Its Performance Chemicals segment provides technology-based solutions for its customers’ processes or products that focuses on the personal care, home care, agrochemical, and metal extraction markets. The company’s Oilfield Services segment develops and markets chemical solutions for fracturing, stimulation, and completion operations; and products for oil and gas production, as well as products to prevent loss of mud in drilling operations. It sells its products primarily to oil and gas exploration and production companies, oil refineries, fuel manufacturers and users, personal care and home care companies, formulators of agrochemical and metal extraction formulations, and other chemical and industrial companies. The company was formerly known as Octel Corp. and changed its name to Innospec Inc. in January 2006. Innospec Inc. was founded in 1938 and is headquartered in Englewood, Colorado.
Click to read more…
Revenue Segmentation
EPS
Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.
Earnings Call
AI summary
Key takeaways
Short, structured highlights from the call so you can focus on what matters.
Log in to continue
Log in to read the full transcript and AI-generated earnings summaries.
Login — it's freeIncome Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | 1,948,800 | 1,845,400 | 1,778,000 |
| Gross Profit | 591,100 | 542,900 | 492,400 |
| EBITDA | 200,900 | 224,600 | 205,600 |
| Operating Income | 161,600 | 177,900 | 156,300 |
| Net Income | 139,100 | 35,600 | 116,600 |
(* All numbers are in thousands)
Balance Sheet
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Total Assets | 1,707,400 | 1,734,700 | 1,832,400 |
| Total Liabilities | 557,800 | 518,600 | 416,000 |
| Total Stockholders Equity | 1,147,100 | 1,211,200 | 1,326,100 |
| Total Debt | 45,200 | 44,900 | 89,500 |
| Cash and Cash Equivalents | 203,700 | 289,200 | 292,500 |
(* All numbers are in thousands)
Cash Flow Statement
| Year | 2023 | 2024 | 2025 |
|---|---|---|---|
| Operating Cash Flow | 207,300 | 184,500 | 138,300 |
| Capital Expenditure | -62,100 | -41,400 | -50,300 |
| Free Cash Flow | 130,100 | 143,100 | 88,000 |
| Net Income | 139,100 | 35,600 | 116,600 |
| Net Change in Cash | 56,600 | 85,500 | 3,300 |
(* All numbers are in thousands)
Analyst Estimates
| Fiscal Year | 2027 | Full Access | Full Access | Full Access | Full Access |
|---|---|---|---|---|---|
| Estimated Revenue (Low) | 1,956,938.914 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (High) | 2,046,798.354 | Full Access | Full Access | Full Access | Full Access |
| Estimated Revenue (Avg) | 2,006,860.826 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Low) | 224,209.791 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (High) | 234,505.138 | Full Access | Full Access | Full Access | Full Access |
| Estimated Ebitda (Avg) | 229,929.428 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Low) | 151,835.980 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (High) | 160,576.532 | Full Access | Full Access | Full Access | Full Access |
| Estimated Net Income (Avg) | 156,206.256 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Low) | 349,629.199 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (High) | 365,683.601 | Full Access | Full Access | Full Access | Full Access |
| Estimated SGA Expense (Avg) | 358,548.311 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Avg) | 6.260 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (High) | 6.420 | Full Access | Full Access | Full Access | Full Access |
| Estimated EPS (Low) | 6.080 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated Revenue) | 2 | Full Access | Full Access | Full Access | Full Access |
| Number of Analysts (Estimated EPS) | 1 | Full Access | Full Access | Full Access | Full Access |
Log in to continue
Log in and subscribe to Full Access to see up to 5 years of analyst estimates.
Login — it's free(* All numbers are in thousands)
Current Key Metrics
Log in to continue
Log in to see all key valuation metrics and ratios for this symbol.
Login — it's freeForward P/E Ratios
Log in to continue
Log in with Full Access for forward P/E high/low estimates and the full multi-year table.
Login — it's freeSWOT Analysis
At what price to buy it? -
Intrinsic Value Calculator
Based on current fundamentals and analyst forecasts, MARKETSnap estimates IOSP intrinsic value between $81.27 – $83.83 per share. This depends on revenue growth, margins, and discount rate.
This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.
Common questions about IOSP valuation
Is Innospec Inc. (IOSP) overvalued or undervalued right now?
MARKETSnap estimates intrinsic value for Innospec Inc. (IOSP) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.
Is IOSP a buy, hold, or sell for long-term investors?
MARKETSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether IOSP trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.
What is IOSP’s P/E ratio?
You can see IOSP’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.
How is intrinsic value calculated for IOSP?
MARKETSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MARKETSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.
Is IOSP a good long-term investment?
Whether IOSP fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MARKETSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.
IOSP
1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.
Daily snapshot
0.26
Chart data temporarily unavailable.
Daily snapshotTrading Metrics:
| Open: | — | Previous Close: | — | |
| Day Low: | — | Day High: | — | |
| Year Low: | Year High: | |||
| Price Avg 50: | Price Avg 200: | |||
| Volume: | Average Volume: | |||
| Session data unavailable | ||||
Log in to continue
Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.
Login — it's free
Relevant news
